SBIR-STTR Award

Electromagnetic field effects on nerve regeneration
Award last edited on: 3/2/07

Sponsored Program
SBIR
Awarding Agency
NIH : NINDS
Total Award Amount
$1,916,260
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Ewa Herbst

Company Information

Herbst Research Inc

PO Box 589
Edgewaler, NJ 07020
   (201) 840-9900
   eherbst@herbst-research.com
   www.herbst-research.com
Location: Single
Congr. District: 09
County: Bergen

Phase I

Contract Number: 1R43NS033033-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1996
Phase I Amount
$100,000
Nerve injuries represent a clinical area that has few adjunctive measures for stimulating regeneration. Therefore, severe nerve injuries often have poor prognosis for regaining function. When there is a long period of denervation, end organs undergo atrophy. With long periods of disability there is, with rare exception, incomplete restoration of function. The long-term goal is to design an optimal signal for promoting peripheral nerve regeneration in humans using electromagnetic field (EMF) stimulation, and thereby to reduce time it takes to reinnervate end organs. The proposed study will focus on a systematic testing of the effects of various electromagnetic fields on nerve regeneration in a sensory nerve model in vitro. A previously developed Multifunctional EMF Stimulator will be redesigned for this purpose. A signal which had previously shown effects on nerve regeneration, both in vitro and in vivo, will be used as the base line for the study. This signal will serve as a first reference in defining which parameters of the EM fields are of most importance, in order to define an optimal signal for future clinical use.PROPOSED COMMERCIAL APPLICATION; Once efficacy of EMF signals on nerve regeneration is proved, an application for FDA approval can be submitted. If approved, this can result in a commercial product to enhance nerve regeneration. There is a large number of clinical nerve injuries with poor prognosis for a full recovery of function. The results can be also of interest in other areas.National Institute of Neurological Disorders and Stroke (NINCDS)

Phase II

Contract Number: 2R44NS033033-02
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
1997
(last award dollars: 2002)
Phase II Amount
$1,816,260

The long-range goal of this project is to develop a clinical method to enhance peripheral nerve regeneration utilizing electromagnetic fields (EMF). To design a signal that promotes the optimal response in regeneration of peripheral nerves, the applicants will perform both in vitro and in vivo experiments in Phase II of this project. The results of Phase I in vitro studies on a chick embryo dorsal root ganglia (DRG) are encouraging. The applicants were able to obtain a significant increase in the neurite length with one out of three electromagnetic fields tested. In Phase II, they will continue to optimize the electrical parameters in vitro and follow with the functional studies in an animal model. If successful, the project will lead to performing clinical trials after completion of the Phase II